Filing Flows › Xtant Medical Holdings (XTNT) › Q1 2026
Xtant Medical Holdings (XTNT) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
Xtant Medical Holdings (XTNT) reported revenue of $20.9M for the first quarter 2026 (Q1 2026), -37% from a year earlier and -35% from the quarter before. Operating margin was -14.0%, net loss $3.1M (14.8% of revenue).
Xtant Medical Holdings, Q1 2026: revenue $20.9M (-36% year over year), operating margin -14.0%, net loss $3.1M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.9M | -35% | -37% |
| Operating profit | −$2.9M | — | -375% |
| Net earnings | −$3.1M | -5519% | -5426% |
| Operating cash flow | −$2.1M | -139% | -265% |
What changed
Revenue was $20.9M in Q1 2026, down 37% year over year and down 35% from the previous quarter. Orthobiologics was the largest line at 75% of revenue. Spinal Implant lost $5.9M year over year (down 53%), 49% of the total change.
Gross margin was 57.3%, down 4.2 points from Q1 2025. Operating costs exceeded revenue by $2.9M, an operating margin of -14.0%. Operating expenses fell 22% while revenue fell 37%. The quarter ended with a net loss of $3.1M, after a profit of $57K the previous quarter.
Operating cash flow was −$2.1M. Non-cash charges added back $534K of depreciation and amortization and $746K of share-based compensation. Working capital and other items used $305K. Capital expenditures of $194K exceeded it, leaving free cash flow of −$2.3M.
Questions
What was Xtant Medical Holdings' revenue in the first quarter 2026?
Xtant Medical Holdings (XTNT) reported revenue of $20.9M for the first quarter 2026 (Q1 2026), -37% from a year earlier and -35% from the quarter before.
Was Xtant Medical Holdings profitable in the first quarter 2026?
Operating loss was $2.9M (-14.0% of revenue) and net loss $3.1M.